MRL-24 displays high affinity for PPARγ with excellent anti-diabetic activity in mice but poor PPARγ agonist activity in transcription and adipogenesis assays. MRL-24 is highly effective (30 nM) at blocking Cdk5-mediated phosphorylation of PPARγ. Cell permeable.
1) Choi et al. (2010), Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by CDK5; Nature, 466 451